aap Implantate AGCHIX:AAQ1D 36 Days Payable is 979.07 as of Dec. 2025, which is 62% above its 10-year median of 604.48. GuruFocus rates CHIX:AAQ1D with a GF Score™ of 36/100 and a GF Value™ of €1.86. The stock has 4 warning signs investors should review. Among 796 Medical Devices & Instruments companies, aap Implantate AG ranks better than 92.46% on this metric.
The historical rank and industry rank for aap Implantate AG's Days Payable or its related term are showing as below:
CHIX:AAQ1d'
s Days Payable Range Over the Past 10 Years
Min: 457.45 Med: 604.48 Max: 1477.04
Current: 497
During the past 13 years, aap Implantate AG's highest Days Payable was 1477.04. The lowest was 457.45. And the median was 604.48.
CHIX:AAQ1d's Days Payable is ranked better than 92.46% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs CHIX:AAQ1d: 497.00
aap Implantate AG's Days Payable
declined
from Dec. 2024 (1,014.58) to Dec. 2025 (979.07).
It may suggest that aap Implantate AGaccelerated paying its suppliers.
aap Implantate AG Days Payable Related Terms
aap Implantate AG Days Payable Historical Data
* Premium members only.
The historical data trend for aap Implantate AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AAQ1D vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, aap Implantate AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aap Implantate AG Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's Days Payable distribution charts can be found below:
* The bar in red indicates where aap Implantate AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
aap Implantate AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aap Implantate AG (CHIX:AAQ1D) has a Days Payable of 979.07 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on aap Implantate AG and its competitors. This is 62% above median its historical median of 604.48. Over the past decade, aap Implantate AG's Days Payable has ranged from 457.45 to 1,477.04. According to the industry distribution chart, aap Implantate AG ranks #60 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 7.5%.
Is aap Implantate AG's Days Payable too high?
aap Implantate AG's current Days Payable of 979.07 is 62% above median its 10-year median of 604.48. Over the past 10 years, this metric has ranged from a low of 457.45 to a high of 1,477.04. The Medical Devices & Instruments industry median Days Payable is 67.97. aap Implantate AG's value of 979.07 is 1340.4% above this industry median. Based on the distribution chart, aap Implantate AG ranks #60 out of 796 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, aap Implantate AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does aap Implantate AG's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, aap Implantate AG ranks #60 out of 796 companies for Days Payable. This places aap Implantate AG in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.97. aap Implantate AG's value of 979.07 is 1340.4% above this benchmark. Historically, aap Implantate AG's own Days Payable has ranged from 457.45 to 1,477.04 over the past decade. While the company's 10-year median is 604.48 vs. the industry median of 67.97, aap Implantate AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. aap Implantate AG's current Days Payable of 979.07 is 1340.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on aap Implantate AG and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aap Implantate AG's current Days Payable is 979.07, which is 62% above median its own 10-year median of 604.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aap Implantate AG stock overvalued right now?
aap Implantate AG (CHIX:AAQ1D) has a current Days Payable of 979.07. The stock's GF Value™ is €1.86, compared to a current price of €3.15 — trading 69.1% above its estimated fair value. The current Days Payable is 979.07, which is 62% above median its 10-year median of 604.48 and 1340.4% above the Medical Devices & Instruments industry median of 67.97. aap Implantate AG's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For aap Implantate AG (CHIX:AAQ1D), the current Days Payable is 979.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aap Implantate AG (CHIX:AAQ1D) Overvalued in 2026?
Based on GuruFocus' analysis, aap Implantate AG stock appears to be overvalued.
The current stock price of €3.15 is trading 69.1% above its estimated GF Value™ of €1.86.
Key valuation signals for CHIX:AAQ1D:
Days Payable: 979.07 (62% above median its 10-year median of 604.48)
GF Value™: €1.86 vs. price of €3.15 (69.1% above fair value)
Industry Position: 1340.4% above the Medical Devices & Instruments median (#60 of 796)
No single metric tells the full story. See the CHIX:AAQ1D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.
36GF Score
Get the complete analysis for CHIX:AAQ1D
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AAQ1D has been successfully added to your 
